Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report

Xin Zhang

doi:10.1016/j.aopr.2022.100025

您当前的位置：

首页 >

文章列表页 >

Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report

更新时间：2023-11-15

- Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report
- Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report
- 眼科实践与研究新进展 2021年1卷第2期页码：100025
- 作者机构：
  
  1. Department of Ophthalmology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine),Hangzhou,China
- 作者简介：
- 基金信息：
- DOI：10.1016/j.aopr.2022.100025
  中图分类号：
扫描看全文
Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report[J]. 眼科实践与研究新进展, 2021,1(2):100025.

Xin Zhang. Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report[J]. AOPR, 2021,1(2):100025.
Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report[J]. 眼科实践与研究新进展, 2021,1(2):100025. DOI： 10.1016/j.aopr.2022.100025.

Xin Zhang. Myelin oligodendrocyte glycoprotein antibody-associated disease following DTaP vaccination: A case report[J]. AOPR, 2021,1(2):100025. DOI： 10.1016/j.aopr.2022.100025.

摘要

Abstract

关键词

Keywords

references

1 S. Salama, M. Khan, S. Pardo, et al.MOG antibody-associated encephalomyelitis/encephalitis Mult Scler, 25 (11) (2019 Oct), pp. 1427-1433, 10.1177/1352458519837705 PubMed PMID: 30907249; PubMed Central PMCID: PMCPMC6751007. eng

2 T.G. Johns, C.C. BernardThe structure and function of myelin oligodendrocyte glycoprotein J Neurochem, 72 (1) (1999 Jan), pp. 1-9, 10.1046/j.1471-4159.1999.0720001.x PubMed PMID: 9886048; eng

3 W. Ambrosius, S. Michalak, W. Kozubski, et al.Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management Int J Mol Sci (1) (2020 Dec 24), p. 22, 10.3390/ijms22010100 PubMed PMID: 33374173; PubMed Central PMCID: PMCPMC7795410. eng

4 S. Tenembaum, T. Chitnis, J. Ness, et al.Acute disseminated encephalomyelitis Neurology, 68 (16 Suppl 2) (2007 Apr 17), pp. S23-S36, 10.1212/01.wnl.0000259404.51352.7f PubMed PMID: 17438235; eng

5 S. Tenembaum, N. Chamoles, N. FejermanAcute disseminated encephalomyelitis: a long-term follow-up study of 84 pediatric patients Neurology, 59 (8) (2002 Oct 22), pp. 1224-1231, 10.1212/wnl.59.8.1224 PubMed PMID: 12391351; eng

6 S. Esposito, G.M. Di Pietro, B. Madini, et al.A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children Autoimmun Rev, 14 (10) (2015 Oct), pp. 923-929, 10.1016/j.autrev.2015.06.002 PubMed PMID: 26079482; PubMed Central PMCID: PMCPMC7105213. eng

7 Q. Xu, W. Du, H. Zhou, et al.Distinct clinical characteristics of paraneoplastic optic neuropathy The British journal of ophthalmology, 103 (6) (2019 Jun), pp. 797-801, 10.1136/bjophthalmol-2018-312046 PubMed PMID: 30021813; eng

8 J.Y. Hor, N. Asgari, I. Nakashima, et al.Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide Front Neurol, 11 (2020), p. 501, 10.3389/fneur.2020.00501 PubMed PMID: 32670177; PubMed Central PMCID: PMCPMC7332882. eng

9 M. Jurynczyk, S. Messina, M.R. Woodhall, et al.Clinical presentation and prognosis in MOG-antibody disease: a UK study Brain : J Neurol, 140 (12) (2017 Dec 1), pp. 3128-3138, 10.1093/brain/awx276 PubMed PMID: 29136091; eng

10 X.J. Li, C. Hou, W. Qiu, et al.[Clinical features and prognosis of pediatric myelin oligodendrocyte glycoprotein antibody associated acute disseminated encephalomyelitis] Zhonghua Yixue Zazhi, 100 (5) (2020 Feb 11), pp. 339-344, 10.3760/cma.j.issn.0376-2491.2020.05.005 PubMed PMID: 32074776; chi

11 R. Marignier, Y. Hacohen, A. Cobo-Calvo, et al.Myelin-oligodendrocyte glycoprotein antibody-associated disease Lancet Neurol, 20 (9) (2021 Sep), pp. 762-772, 10.1016/s1474-4422(21)00218-0 PubMed PMID: 34418402; eng

12 F. Bartels, A. Lu, F.C. Oertel, et al.Clinical and neuroimaging findings in MOGAD-MRI and OCT Clin Exp Immunol, 206 (3) (2021 Dec), pp. 266-281, 10.1111/cei.13641 PubMed PMID: 34152000; PubMed Central PMCID: PMCPMC8561692. eng

13 H. Liu, H. Zhou, J. Wang, et al.The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis J Neurol Sci, 396 (2019 Jan 15), pp. 225-231, 10.1016/j.jns.2018.11.029 PubMed PMID: 30522039; eng

14 Y. Takai, T. Misu, K. Kaneko, et al.Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study Brain : J Neurol, 143 (5) (2020 May 1), pp. 1431-1446, 10.1093/brain/awaa102 PubMed PMID: 32412053; eng

15 E.M. Hennes, M. Baumann, K. Schanda, et al.Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome Neurology, 89 (9) (2017 Aug 29), pp. 900-908, 10.1212/wnl.0000000000004312 PubMed PMID: 28768844; eng

16 L. Bennetto, N. ScoldingInflammatory/post-infectious encephalomyelitis J Neurol Neurosurg Psychiatry, 75 (Suppl 1) (2004 Mar), pp. i22-i28, 10.1136/jnnp.2003.034256 PubMed PMID: 14978147; PubMed Central PMCID: PMCPMC1765651. eng

17 W. Küker, J. Ruff, S. Gaertner, et al.Modern MRI tools for the characterization of acute demyelinating lesions: value of chemical shift and diffusion-weighted imaging Neuroradiology, 46 (6) (2004 Jun), pp. 421-426, 10.1007/s00234-004-1203-5 PubMed PMID: 15114427; eng

18 G. Berzero, A. Cortese, S. Ravaglia, et al.Diagnosis and therapy of acute disseminated encephalomyelitis and its variants Expert Rev Neurother, 16 (1) (2016), pp. 83-101, 10.1586/14737175.2015.1126510 PubMed PMID: 26620160; eng

19 D.J. Sahlas, S.P. Miller, M. Guerin, et al.Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin Neurology, 54 (6) (2000 Mar 28), pp. 1370-1372, 10.1212/wnl.54.6.1370 PubMed PMID: 10746613; eng

20 D.A. Tajfirouz, M.T. Bhatti, J.J. ChenClinical characteristics and treatment of MOG-IgG-associated optic neuritis Curr Neurol Neurosci Rep, 19 (12) (2019 Nov 26), p. 100, 10.1007/s11910-019-1014-z PubMed PMID: 31773369; eng

21 J.J. Chen, M.T. BhattiClinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis Curr Opin Neurol, 33 (1) (2020 Feb), pp. 47-54, 10.1097/wco.0000000000000766 PubMed PMID: 31743235; eng

查看原文

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据